Healthcare | June 23, 2026
QMS Medical targets Rs. 500 crore revenue by FY29
The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26
The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26
Acquisition of Mumbai-based pharmaceutical, nutraceutical and cosmeceutical company expected to be completed by July 2026
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation
Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
